These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32104382)

  • 1. Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis.
    Chennakesavulu S; Mishra A; Sudheer A; Sowmya C; Suryaprakash Reddy C; Bhargav E
    Asian J Pharm Sci; 2018 Jan; 13(1):91-100. PubMed ID: 32104382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary disposition of budesonide from liposomal dry powder inhaler.
    Joshi M; Misra AN
    Methods Find Exp Clin Pharmacol; 2001 Dec; 23(10):531-6. PubMed ID: 11957743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal budesonide for dry powder inhaler: preparation and stabilization.
    Joshi MR; Misra A
    AAPS PharmSciTech; 2001 Nov; 2(4):25. PubMed ID: 14727862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.
    Chougule MB; Padhi BK; Misra A
    J Nanosci Nanotechnol; 2006; 6(9-10):3001-9. PubMed ID: 17048511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of spray dried liposomal dry powder inhaler of Dapsone.
    Chougule M; Padhi B; Misra A
    AAPS PharmSciTech; 2008; 9(1):47-53. PubMed ID: 18446460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of liposomal salbutamol sulfate dry powder inhaler formulation.
    Huang WH; Yang ZJ; Wu H; Wong YF; Zhao ZZ; Liu L
    Biol Pharm Bull; 2010; 33(3):512-7. PubMed ID: 20190418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics.
    Chougule M; Padhi B; Misra A
    Int J Nanomedicine; 2007; 2(4):675-88. PubMed ID: 18203434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.
    Ambrus R; Benke E; Farkas Á; Balásházy I; Szabó-Révész P
    Eur J Pharm Sci; 2018 Oct; 123():20-27. PubMed ID: 30016647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of liposomal amphotericin B dry powder inhaler formulation.
    Shah SP; Misra A
    Drug Deliv; 2004; 11(4):247-53. PubMed ID: 15371106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal dry powders as aerosols for pulmonary delivery of proteins.
    Lu D; Hickey AJ
    AAPS PharmSciTech; 2005 Dec; 6(4):E641-8. PubMed ID: 16408866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
    Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
    Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of βcyclodextrin-based nanosponges loaded with Budesonide for pulmonary delivery.
    Salem YY; Hoti G; Sammour RMF; Caldera F; Cecone C; Matencio A; Shahiwala AF; Trotta F
    Int J Pharm; 2023 Nov; 647():123529. PubMed ID: 37858636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
    Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
    Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility.
    Akdag Y
    Pharm Dev Technol; 2023 Jan; 28(1):124-137. PubMed ID: 36602194
    [No Abstract]   [Full Text] [Related]  

  • 19. Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.
    Kinnunen H; Hebbink G; Peters H; Huck D; Makein L; Price R
    Int J Pharm; 2015 Jan; 478(1):53-59. PubMed ID: 25448567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy.
    Honmane S; Hajare A; More H; Osmani RAM; Salunkhe S
    J Liposome Res; 2019 Dec; 29(4):332-342. PubMed ID: 30296863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.